Chapter 7: Postanalysis Flashcards

1
Q

Indicate problem with the specimens or an issue with the result
Prevent the release of erroneous laboratory

A

Alarms and Flags

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Additional Steps in Flagging Specimens

A
  • by automated instrument itself
  • by specialized middleware
  • by laboratory information system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Flags for Problem Specimen

A
  • sample contain amounts inadequate for reliable analysis

- presence of high concentration of interfering substances in the specimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • instrument that can often analyze more than 100 samples per hour
A

Automated Cell Counters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of samples can be reported immediately?

A

Normal Sample or Samples that show Quantitative Abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Flagged for preparation of blood smear and further evaluation

A

Samples that could contain qualitative abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens to an analyte concentration outside the validated linear range?

A
  • increase in signal linearity related to inc. in conc.
  • above the linear range, the machine dilutes and renanalyze sample
  • below LR, sample is reported as “less than the limit of detection”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The process of conparing a current laboratory result with results obtained on a previous specimen from the same patient

A

Delta Checks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of Errors Detected by Delta Checks

A
  • preanalytic and analytic issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

May not be readily detectable

Must be reported immediately to a healthcare provider

A

Critical Values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Required rapid communication of laboratory results

A

Federal Law, Regulatory Agencies, and Joint Commission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Develops a crticial values policy that meets the needs of the patients and staff served by the laboratory

A

Medical Director of the Laboratory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Definition of Reference Intervals

A

Laboratory Results vs Reference or Normal Range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • Range of values into which 95% of non-diseased individuals will fall
  • *some of these analytes is defined as “greater than” or “less than” a certain value
  • some have been defined by prof. org. w/out adherence to the 95% rule
A

Reference Ranges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Does not require reference intervals except if the patient population was clearly distinct and exhibited range of values

A

Standardization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The Joint Committee for Traceability in Laboratory Machine establishes process for standardization by:

A
  1. Identifying
  2. Reviewing against agreed criteria
  3. Publishing list(s) of Higher Order Certified Reference Materials and Reference Measurement Procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Calibrating and using materials traceable to isotope dilution mass spectrometry reference measurement procedure

A

Reduce Interlaboratory Variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Factors that Influence Reference Ranges

A
Age
Genetic background
Exposure to environmental factors
Sample collection container
Sample transport
Time between specimen collection and analysis
Sample storage before analysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Determination of Reference Ranges

A
  • Testing at least 120 SAMPLES from nondiseased individuals in each “partition”
  • Transference
  • Verication by another lab’s or the manufacturer’s reference interval if the analyte was not previously tested for the lab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Verification of a reference interval that was previously established for a different method

A

Transference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Result of assay imprecision

A

Analytic Variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Due to biologic changes that cause analyte levels to fluctuate over time

A

Intraindividuality Variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Occurs becauuse of factors specific to individual patients

A

Interindividuality Variation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

The sum analytic and intraindividuality variability

A

Random Variability

25
Used for disease classification (positive or negative)
Threshold
26
Based on the results that are seen in 95% of the healthy population
Reference Range / Interval
27
Determined by comparing test's ability to discern true disease from nondisease
Diagnostic Accuracy
28
Used to discern true disease from nondisease
Diagnostic Gold Standard
29
The non-overlapping areas of the two patient distribution.
True Results
30
Classified as Abnormal
True Positive (TP)
31
Classified as Normal
True Negative (TN)
32
Used to discriminate disease from normal populations
Single Cutoff
33
The overlapping areas of the two patient distribution
False Results
34
INCORRECTLY classified as NORMAL
False-Negative (FN)
35
INCORRECTLY classified as ABNORMAL
False-Positive (FP)
36
The error of True Positive
False-Negative
37
The error of True Negative
False-Positive
38
Measures of diagnostic accuracy | Indicators in distinguishing the presence and absence of disease at a chosen cutoff
Sensitivity and Specificity
39
● The ability of a test to detect disease. ● The proportion of persons with the disease. ● TRUE POSITIVE (TP) ● Identifies a greater proportion of persons with the disease.
Sensitivity
40
● The ability of a test to detect the absence of disease ● The proportion of persons without the disease. ● TRUE-NEGATIVE (TN) ● Excludes a greater proportion of persons without the disease.
Specificity
41
Effect of Altering the Test Cutoff
● Altering the cutoff changes a test’s sensitivity and specificity. ● An inverse relationship between SENSITIVITY AND SPECIFICITY is noted.
42
For tests where high values indicate disease, lowering cutoff (cutoff line moved to the left) will lead to more diseased patients being classified as abnormal.
HIGH SENSITIVITY
43
If the cutoff is raised (the cutoff line moved to the right), more non-diseased patients are classified correctly.
HIGH SPECIFICITY.
44
The Need for High Sensitivity vs High Specificity
● False results such as FP (false-positive) and FN (false-negative) can lead to misdiagnosis and inappropriate clinical management. ● SENSITIVITY should be HIGH to capture the majority of cases. (Lowering cutoff) ● SPECIFICITY can be INCREASED to exclude all persons without the disease. (Increasing cutoff).
45
 sometimes referred to as positive predictive value  may be understood as the probability that a positive test indicates disease  it is the proportion of persons with a positive test who have truly the disease.
PREDICTIVE VALUE OF A POSITIVE TEST
46
 Referred to as negative predictive value  Is the probability that a negative test indicates absence of disease  It is the proportion of persons with a negative test who are true without disease
PREDICTIVE VALUE OF A NEGATIVE TEST
47
Relationship of Prevalence and Posttest Probability
The higher the prevalence, or pretest probability, the higher the posttest probability, or predictive value of a positive test.
48
- Shows that sensitivity and specificity influence the predictive value. - Describes the relationship between posttest and pretest probability of disease or no disease based on the sensitivity and specificity of the test
Bayes Theorem
49
Also known as priori probability, is the prevalence of the disease in the patient’s clinical setting - used in conjunction with the characteristics of diagnostic accuracy as summarized in the sensitivity and specificity of the test.
Pretest probability
50
Also known as posteriori probability, is the probability of disease in the posttest situation and is commonly referred to as the predictive value of the test.
Posttest probability
51
● A convenient measure that combines sensitivity and specificity into a single number specificity into a single number. ● An assessment of test performance, and not of disease status, in the patient being tested.
Likelihood Ratio
52
The LR+ is the ratio of two probabilities: the probability of a positive test result when the disease is present (TP) divided by the probability of the same test result when the disease is absent (FP).
Likelihood Ratio of a positive test (LR+)
53
A convenient graphic tool that uses a logarithmic scale to determine posttest probability, given the LR at a specified cutoff and the pretest probability
FAGAN NOMOGRAM
54
a useful tool for identifying the optimal cutoff for a diagnostic test by calculating the sensitivity and specificity combinations across the entire range of cut off values
RECEIVER OPERATOR CHARACTERISTIC CURVE
55
a method that allows one to assess the optimal cutoff with numeric estimates for clinical impact, or consequences, of test results.
POSITIVITY CRITERION
56
• Is a process by which medical decision can be made by using as many objective tools as possible. • Can help to reduce the uncertainty of medical decision making.
EVIDENCE-BASED MEDICINE
57
5 Steps of EBM
1. Ask a clinical question based on a patient encounter 2. Acquire information by searching for resources 3. Analyze and critically evaluate the information and reach a conclusion 4. Apply the information to individual patients 5. Audit effectiveness and monitor the literature
58
The clinical question can be described in four parts with | acronym of PICO
- Problem - Intervention - Comparison - Outcome